Lewicki John A.'s Form 4 filing
Mereo BioPharma Group plc (MREO) · filed Sep 16, 2024
- Accession no.
- 0000950170-24-106974
- Filed
- Sep 16, 2024
- Trade date
- Sep 12-13, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $69.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lewicki John A.CIK 0001553352 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2024 | American Depositary Shares representing Ordinary Shares | SSaleDisposed | −5,212 | $4.47 | −$23,297.64 | 89,567 | Direct | |
| Sep 13, 2024 | American Depositary Shares representing Ordinary Shares | SSaleDisposed | −10,937 | $4.22 | −$46,154.14 | 78,630 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.